Literature DB >> 6431462

Amoxapine and amitriptyline. II. Specificity of cognitive effects during brief treatment of depression.

D M McNair, R J Kahn, L M Frankenthaler, L L Faldetta.   

Abstract

Cognitive effects of brief antidepressant treatments were studied in depressed outpatients assigned double-blind to equipotent doses of amoxapine or amitriptyline in a 12-week double-crossover of 3-week periods of active agent and placebo. The two drugs had different profiles of effects: amitriptyline was associated with faster reaction time on tests of attention and immediate memory, reduced accuracy on an attention task, and impaired long-term memory (after 1 but not 3 weeks); amoxapine slowed performance and increased intraperson variability on a psychomotor coordination task. Amitriptyline facilitated performance in the more depressed patients, and amoxapine in the older patients. Both agents also increased pulse rate and reduced palmar sweating.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6431462     DOI: 10.1007/bf00429721

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

Review 1.  Psychological deficit in depression.

Authors:  W R Miller
Journal:  Psychol Bull       Date:  1975-03       Impact factor: 17.737

2.  Antidepressants and the muscarinic acetylcholine receptor.

Authors:  S H Snyder; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1977-02

3.  A continuous performance test of brain damage.

Authors:  L H BECK; E D BRANSOME; A F MIRSKY; H E ROSVOLD; I SARASON
Journal:  J Consult Psychol       Date:  1956-10

4.  The Hopkins Symptom Checklist (HSCL)--factors derived from the HSCL-90.

Authors:  R S Lipman; L Covi; A K Shapiro
Journal:  J Affect Disord       Date:  1979-03       Impact factor: 4.839

5.  Screening for anticholinergic effects of atropine and chlordiazepoxide.

Authors:  L F Droppleman; D M McNair
Journal:  Psychopharmacologia       Date:  1968

6.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

7.  Simulated public speaking as a model of clinical anxiety.

Authors:  D M McNair; L M Frankenthaler; T Czerlinsky; T W White; S Sasson; S Fisher
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Memory functions in depression.

Authors:  D E Sternberg; M E Jarvik
Journal:  Arch Gen Psychiatry       Date:  1976-02

9.  Amoxapine and amitriptyline. I. Relative speed of antidepressant action.

Authors:  D M McNair; R J Kahn; L M Frankenthaler; L L Faldetta
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06
View more
  7 in total

1.  Effects of physostigmine on stimulus encoding in a memory-scanning task.

Authors:  A Wetherell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 2.  Antidepressant versus placebo for depressed elderly.

Authors:  K Wilson; P Mottram; A Sivanranthan; A Nightingale
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 3.  Performance tests.

Authors:  A Wetherell
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

4.  The effects of St John's wort extract on heart rate variability, cognitive function and quantitative EEG: a comparison with amitriptyline and placebo in healthy men.

Authors:  M Siepmann; S Krause; P Joraschky; M Mück-Weymann; W Kirch
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

5.  Amoxapine and amitriptyline. I. Relative speed of antidepressant action.

Authors:  D M McNair; R J Kahn; L M Frankenthaler; L L Faldetta
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients.

Authors:  B Spring; A J Gelenberg; R Garvin; S Thompson
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  The spectrum of disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu
Journal:  Brain       Date:  2012-12-02       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.